BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15561930)

  • 1. The potential role of SOCS-3 in the interleukin-1beta-induced desensitization of insulin signaling in pancreatic beta-cells.
    Emanuelli B; Glondu M; Filloux C; Peraldi P; Van Obberghen E
    Diabetes; 2004 Dec; 53 Suppl 3():S97-S103. PubMed ID: 15561930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity.
    Karlsen AE; Rønn SG; Lindberg K; Johannesen J; Galsgaard ED; Pociot F; Nielsen JH; Mandrup-Poulsen T; Nerup J; Billestrup N
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12191-6. PubMed ID: 11593036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated proapoptotic pathways.
    Karlsen AE; Heding PE; Frobøse H; Rønn SG; Kruhøffer M; Orntoft TF; Darville M; Eizirik DL; Pociot F; Nerup J; Mandrup-Poulsen T; Billestrup N
    Diabetologia; 2004 Nov; 47(11):1998-2011. PubMed ID: 15578154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1beta and suppressor of cytokine signalling-1 in mouse pancreatic beta cells.
    Venieratos PD; Drossopoulou GI; Kapodistria KD; Tsilibary EC; Kitsiou PV
    Cell Signal; 2010 May; 22(5):791-800. PubMed ID: 20067833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
    Kwon G; Corbett JA; Hauser S; Hill JR; Turk J; McDaniel ML
    Diabetes; 1998 Apr; 47(4):583-91. PubMed ID: 9568691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms.
    Ueki K; Kondo T; Kahn CR
    Mol Cell Biol; 2004 Jun; 24(12):5434-46. PubMed ID: 15169905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.
    Senn JJ; Klover PJ; Nowak IA; Zimmers TA; Koniaris LG; Furlanetto RW; Mooney RA
    J Biol Chem; 2003 Apr; 278(16):13740-6. PubMed ID: 12560330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone down-regulation of Interleukin-1beta and Interleukin-6 induced acute phase protein gene expression is associated with increased gene expression of suppressor of cytokine signal-3.
    Wu X; Herndon DN; Wolf SE
    Shock; 2003 Apr; 19(4):314-20. PubMed ID: 12688541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines.
    Santangelo C; Scipioni A; Marselli L; Marchetti P; Dotta F
    Eur J Endocrinol; 2005 Mar; 152(3):485-9. PubMed ID: 15757867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor of cytokine signaling 1 protects rat pancreatic islets from cytokine-induced apoptosis through Janus kinase/signal transducers and activators of transcription pathway.
    Sun Q; Xiang RL; Yang YL; Feng K; Zhang K; Ding WY
    Chin Med J (Engl); 2013 Nov; 126(21):4048-53. PubMed ID: 24229672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation.
    Kim MJ; Ryu GR; Kang JH; Sim SS; Min DS; Rhie DJ; Yoon SH; Hahn SJ; Jeong IK; Hong KJ; Kim MS; Jo YH
    Biochem Pharmacol; 2004 Nov; 68(9):1775-85. PubMed ID: 15450943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 1-hour pulse with IL-1 beta induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: evidence for a tyrosine kinase signaling mechanism.
    Corbett JA; Sweetland MA; Lancaster JR; McDaniel ML
    FASEB J; 1993 Feb; 7(2):369-74. PubMed ID: 8440413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOCS-1 protein prevents Janus Kinase/STAT-dependent inhibition of beta cell insulin gene transcription and secretion in response to interferon-gamma.
    Cottet S; Dupraz P; Hamburger F; Dolci W; Jaquet M; Thorens B
    J Biol Chem; 2001 Jul; 276(28):25862-70. PubMed ID: 11342558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic beta cells to tumor necrosis factor.
    Chong MM; Thomas HE; Kay TW
    J Biol Chem; 2002 Aug; 277(31):27945-52. PubMed ID: 12032139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metallothionein induction in islets of Langerhans and insulinoma cells.
    Laychock SG; Duzen J; Simpkins CO
    Mol Cell Endocrinol; 2000 Jul; 165(1-2):179-87. PubMed ID: 10940496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
    Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
    Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems.
    Calegari VC; Alves M; Picardi PK; Inoue RY; Franchini KG; Saad MJ; Velloso LA
    Endocrinology; 2005 Feb; 146(2):579-88. PubMed ID: 15514089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
    Wadt KA; Larsen CM; Andersen HU; Nielsen K; Karlsen AE; Mandrup-Poulsen T
    Diabetes; 1998 Oct; 47(10):1602-8. PubMed ID: 9753298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1beta regulates phospholipase D-1 expression in rat pancreatic beta-cells.
    Chen MC; Paez-Espinosa V; Welsh N; Eizirik DL
    Endocrinology; 2000 Aug; 141(8):2822-8. PubMed ID: 10919268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual functional effects of interleukin-1beta on purine nucleotides and insulin secretion in rat islets and INS-1 cells.
    Meredith M; Rabaglia ME; Corbett JA; Metz SA
    Diabetes; 1996 Dec; 45(12):1783-91. PubMed ID: 8922366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.